Navigation Links
Common Painkillers Might Boost Odds for 2nd Heart Attack

By Steven Reinberg
HealthDay Reporter

MONDAY, Sept. 10 (HealthDay News) -- People who've already suffered a heart attack may face higher odds of death or subsequent heart attack if they regularly take a common form of painkiller, Danish researchers report.

The painkillers are known as nonsteroidal anti-inflammatory drugs (NSAIDs), and include over-the-counter drugs such as ibuprofen (Advil, Motrin) and naproxen (Aleve), as well as prescription drugs such as Celebrex (celecoxib), the researchers noted.

"These results support previous findings that NSAIDs have no apparent safe treatment window among patients with a [prior] heart attack," said lead researcher Dr. Anne-Marie Schjerning Olsen from the department of cardiology at the University of Copenhagen. "Long-term caution with use of NSAIDs is advised in all patients after a heart attack," she said.

Olsen added that "it is important to get the message out to clinicians taking care of patients with cardiovascular disease that NSAIDs are harmful, even several years after a heart attack."

The report was published in the Sept. 10 issue of Circulation.

For the study, researchers collected data on almost 100,000 people who had experienced a heart attack between 1997 and 2009. They found that 44 percent of these patients had filled at least one prescription for an NSAID.

Compared to non-users, people who took the painkillers had a 59 percent higher risk of dying from any cause within a year after their heart attack, and a 63 percent higher risk within five years, the researchers found.

In addition, the risk of having another heart attack or dying from heart disease increased 30 percent within one year, and 41 percent after five years, the Danish team said.

These findings were the same for men and women regardless of age and income, the researchers found, and the study also accounted for factors such as other illnesses or medications.

Still, the data comes from what's known as an observational study, so it cannot prove that NSAIDs helped cause the deaths and heart attacks -- only that there was an association.

Nevertheless, the use of these drugs should be limited and the ability to buy them over-the-counter should be reconsidered, the researchers concluded.

"It has been shown in multiple prior studies that regular use of NSAIDs, including those that are available over the counter, is associated with increased risk of cardiovascular events," noted Dr. Gregg Fonarow, a spokesman for the American Heart Association and a professor of cardiology at the University of California, Los Angeles, who was not involved with the study.

"Even short-term use in patients after a heart attack or with heart failure has been associated with excess risk," he said.

Since 2007, American Heart Association guidelines have warned of the potential cardiovascular risk of NSAIDs in patients with established cardiovascular disease and after a heart attack and discouraged their use in these patients, Fonarow noted.

"This study highlights that substantial caution is necessary when considering NSAIDs in patients after a heart attack no matter how long ago the heart attack occurred," he said.

"Patients with a history [of heart attack] should consult with their physicians before taking NSAIDs, including those that are available over the counter," Fonarow added.

After a heart attack patients are usually prescribed aspirin, which is also an NSAID. However, "these findings do not apply to aspirin, which is a protective therapy after a heart attack," Fonarow stressed.

More information

For more information on heart attack, visit the American Heart Association.

SOURCES: Anne-Marie Schjerning Olsen, M.D., department of cardiology, University of Copenhagen, Denmark; Gregg Fonarow, M.D., spokesman, American Heart Association, and professor, cardiology, University of California, Los Angeles; Sept. 10, 2012, Circulation

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Texting in College Classrooms Common, Distracting
2. Recovery from propofol anesthesia may be sped by use of common stimulant
3. Long-term neuropsychological impairment is common in acute lung injury survivors
4. Overuse Injuries Common Among Female College Athletes
5. Common Blood Pressure Drug Safe for Heart Failure: Study
6. Test links strains of common parasite to severe illness in US newborns
7. Common Plastics Chemical Might Boost Diabetes Risk
8. Off-Label Drug Use Appears Common
9. Global, common approach to pharmaceutical supply chain integrity the focus of workshop
10. Slow-growing babies more likely in normal-weight women; Less common in obese pregnancies
11. Common Blood Pressure Drugs May Not Cut Colon Cancer Risk
Post Your Comments:
Related Image:
Common Painkillers Might Boost Odds for 2nd Heart Attack
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... ... , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department ... in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at ... Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
Breaking Medicine Technology: